mPGES-1 inhibitors (Bayer/Evotec)

N/A

Report date: 2025/03/20 15:01:30
NME

Base Information

Drug NamemPGES-1 inhibitors (Bayer/Evotec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E synthase inhibitors
TargetsProstaglandin E synthase
Therapy Area/IndicationsPainEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGEvotec SE
Inactive CompaniesN/A
Active IndicationsPainEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A